Literature DB >> 19749180

Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice.

Angela M Hall1, Elizabeth M Brunt, Zhouji Chen, Navin Viswakarma, Janardan K Reddy, Nathan E Wolins, Brian N Finck.   

Abstract

Lipid droplet proteins (LDPs) coat the surface of triglyceride-rich lipid droplets and regulate their formation and lipolysis. We profiled hepatic LDP expression in fatty liver dystrophic (fld) mice, a unique model of neonatal hepatic steatosis that predictably resolves between postnatal day 14 (P14) and P17. Western blotting revealed that perilipin-2/ADRP and perilipin-5/OXPAT were markedly increased in steatotic fld liver but returned to normal by P17. However, the changes in perilipin-2 and perilipin-5 protein content in fld mice were exaggerated compared with relatively modest increases in corresponding mRNAs encoding these proteins, a phenomenon likely mediated by increased protein stability. Conversely, cell death-inducing DFFA-like effector (Cide) family genes were strongly induced at the level of mRNA expression in steatotic fld mouse liver. Surprisingly, levels of peroxisome proliferator-activated receptor gamma, which is known to regulate Cide expression, were unchanged in fld mice. However, sterol-regulatory element binding protein 1 (SREBP-1) was activated in fld liver and CideA was revealed as a new direct target gene of SREBP-1. In summary, LDP content is markedly increased in liver of fld mice. However, whereas perilipin-2 and perilipin-5 levels are primarily regulated posttranslationally, Cide family mRNA expression is induced, suggesting that these families of LDP are controlled at different regulatory checkpoints.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19749180      PMCID: PMC2817585          DOI: 10.1194/jlr.M000976

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  50 in total

1.  Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression.

Authors:  Songtao Yu; Kimihiko Matsusue; Papreddy Kashireddy; Wen-Qing Cao; Vaishalee Yeldandi; Anjana V Yeldandi; M Sambasiva Rao; Frank J Gonzalez; Janardan K Reddy
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

2.  Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice.

Authors:  J Martinez-Botas; J B Anderson; D Tessier; A Lapillonne; B H Chang; M J Quast; D Gorenstein; K H Chen; L Chan
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

3.  S3-12, Adipophilin, and TIP47 package lipid in adipocytes.

Authors:  Nathan E Wolins; Benjamin K Quaynor; James R Skinner; Marissa J Schoenfish; Anatoly Tzekov; Perry E Bickel
Journal:  J Biol Chem       Date:  2005-02-24       Impact factor: 5.157

4.  Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet.

Authors:  Wataru Motomura; Mitsutaka Inoue; Takaaki Ohtake; Nubuhiko Takahashi; Miho Nagamine; Satoshi Tanno; Yutaka Kohgo; Toshikatsu Okumura
Journal:  Biochem Biophys Res Commun       Date:  2005-12-28       Impact factor: 3.575

5.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

Authors:  Kimihiko Matsusue; Martin Haluzik; Gilles Lambert; Sun-Hee Yim; Oksana Gavrilova; Jerrold M Ward; Bryan Brewer; Marc L Reitman; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

6.  PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.

Authors:  Susan E Schadinger; Nancy L R Bucher; Barbara M Schreiber; Stephen R Farmer
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-01-11       Impact factor: 4.310

7.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.

Authors:  Jay D Horton; Nila A Shah; Janet A Warrington; Norma N Anderson; Sahng Wook Park; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

Review 8.  Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis.

Authors:  Dawn L Brasaemle
Journal:  J Lipid Res       Date:  2007-09-18       Impact factor: 5.922

Review 9.  CIDE proteins and metabolic disorders.

Authors:  Jingyi Gong; Zhiqi Sun; Peng Li
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

10.  Control of phospholipid synthesis by phosphorylation of the yeast lipin Pah1p/Smp2p Mg2+-dependent phosphatidate phosphatase.

Authors:  Laura O'Hara; Gil-Soo Han; Sew Peak-Chew; Neil Grimsey; George M Carman; Symeon Siniossoglou
Journal:  J Biol Chem       Date:  2006-09-12       Impact factor: 5.157

View more
  26 in total

Review 1.  The role of lipid droplets in metabolic disease in rodents and humans.

Authors:  Andrew S Greenberg; Rosalind A Coleman; Fredric B Kraemer; James L McManaman; Martin S Obin; Vishwajeet Puri; Qing-Wu Yan; Hideaki Miyoshi; Douglas G Mashek
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  A single centrifugation method for isolating fat droplets from cells and tissues.

Authors:  Lydia-Ann L S Harris; Trevor M Shew; James R Skinner; Nathan E Wolins
Journal:  J Lipid Res       Date:  2012-02-11       Impact factor: 5.922

3.  Liver-specific loss of lipin-1-mediated phosphatidic acid phosphatase activity does not mitigate intrahepatic TG accumulation in mice.

Authors:  George G Schweitzer; Zhouji Chen; Connie Gan; Kyle S McCommis; Nisreen Soufi; Roman Chrast; Mayurranjan S Mitra; Kui Yang; Richard W Gross; Brian N Finck
Journal:  J Lipid Res       Date:  2015-02-26       Impact factor: 5.922

4.  Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse.

Authors:  Liang Bai; Yuzhi Jia; Navin Viswakarma; Jiansheng Huang; Aurore Vluggens; Nathan E Wolins; Nadereh Jafari; M Sambasiva Rao; Jayme Borensztajn; Gongshe Yang; Janardan K Reddy
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

Review 5.  Pathophysiology of lipid droplet proteins in liver diseases.

Authors:  Rotonya M Carr; Rexford S Ahima
Journal:  Exp Cell Res       Date:  2015-10-26       Impact factor: 3.905

6.  Adipose differentiation-related protein regulates lipids and insulin in pancreatic islets.

Authors:  D M Faleck; K Ali; R Roat; M J Graham; R M Crooke; R Battisti; E Garcia; R S Ahima; Y Imai
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-05-18       Impact factor: 4.310

7.  Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet.

Authors:  Joel R Garbow; Jason M Doherty; Rebecca C Schugar; Sarah Travers; Mary L Weber; Anna E Wentz; Nkiruka Ezenwajiaku; David G Cotter; Elizabeth M Brunt; Peter A Crawford
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-31       Impact factor: 4.052

Review 8.  Dual function lipin proteins and glycerolipid metabolism.

Authors:  Thurl E Harris; Brian N Finck
Journal:  Trends Endocrinol Metab       Date:  2011-04-04       Impact factor: 12.015

9.  Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease.

Authors:  James L McManaman; Elise S Bales; David J Orlicky; Matthew Jackman; Paul S MacLean; Shannon Cain; Amanda E Crunk; Ayla Mansur; Christine E Graham; Thomas A Bowman; Andrew S Greenberg
Journal:  J Lipid Res       Date:  2013-02-12       Impact factor: 5.922

10.  Mice with an adipocyte-specific lipin 1 separation-of-function allele reveal unexpected roles for phosphatidic acid in metabolic regulation.

Authors:  Mayurranjan S Mitra; Zhouji Chen; Hongmei Ren; Thurl E Harris; Kari T Chambers; Angela M Hall; Karim Nadra; Samuel Klein; Roman Chrast; Xiong Su; Andrew J Morris; Brian N Finck
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.